Actio Biosciences, a clinical-stage biotechnology company advancing the translation of genetic insights into novel precision ...
The main market opportunities involve providing training and solutions for regulatory compliance and V&V best practices in regulated industries. This includes developing Master Validation Plans, ...
Global strategic collaboration with Astellas to advance PSMA-targeted, PRO-XTEN® dual-masked T-cell engager (TCE) VIR-5500 ...
Dublin, April 15, 2026 (GLOBE NEWSWIRE)-- The "Mastering Aseptic Processing for Pharmaceutical & Biotech Manufacturing (Mar 24th - Mar 25th, 2026)" training has been added to ResearchAndMarkets.com's ...
Partnership combines world-class protein engineering with scalable drug development to accelerate innovationBOSTON--(BUSINESS WIRE)--Alloy Therapeutics, a leading biotechnology ecosystem company, ...
Potency assay development uses DoE and QbD to improve accuracy, consistency, and regulatory readiness in biologics testing.
WASHINGTON, DC / ACCESS Newswire / May 8, 2026 / American DeepTech, an investment firm focused on next-generation ...
Alloy Therapeutics and Institute for Protein Innovation collaborate to advance next-generation antibody discovery: Boston Wednesday, May 6, 2026, 15:00 Hrs [IST] Alloy Therapeutic ...
Green and Sustainable Chemistry can take up new challenges solving past, present and preventing future environmental burdens.
In this Pharma Matters Q&A, Anshul Gupte of PCI Pharma Services discusses investments and opportunities in sterile ...
Company Expands Ownership-Driven Investment Model While Maintaining Insurance and InsurTech Operating FoundationCompany to Host Conference Call ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results